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Abstract 
Introduction: Prostate is a male organ which might enlarge mostly, either benign 
or malignant. Hyperglycemia is one of the factor that increase the risk of  benign 
prostate hyperplasia. There is lack of studies which assessed the relationship 
between benign prostate hyperplasia and isolated hyperglycemia. The aim of this 
study was to evaluate the association between hyperglycemia and prostate volume 
in patients with benign prostate enlargement in dr. Kariad i Hospital Semarang.   
Method: We conducted a retrospective analysis of clinical data which obtained 
from 640 men between 2010 and 2012 who admitted to the hospital with diagnosis 
of benign prostate enlargement. By their medical records, these patients were 
evaluated of their plasma glucose level and prostate volume by trans rectal 
ultrasound. The  presence  of  hyperglycemia  was  determined  based  on  the  
American  Diabetes Association (ADA) and the European Association for the 
Study of Diabetes (EASD). Patients have already been diagnosed with controlled 
diabetes mellitus by an internist. We allocated the subjects into two groups: 
patients with hyperglycemia and non-hyperglycemia. Logistic regression analysis 
was used to assess whether hyperglycemia was associated with the increased risk 
of benign prostate enlargement.  
Results: Significant difference of prostate volume found between groups. Prostate 
volume was  significantly greater in hyperglycemia group compared with non -
hyperglycemia ones in all sub-groups based on age (in decades). Odds Ratio (OR) 
in patients with hyperglycemia was 2.25 (95% CI: 1.23-4.11). By non-parametric 
Spearman test it obtained  Group 1 (P1) p  = 0.000 and r = 0.669, group 2 (P2) it  
obtained p = 0.000 and r = 0.672, group 3 (P3) it obtained p = 0.000 and r = 0.415 
which implied strong positive association 
Conclusion: Hyperglycemia and prostate volume were significantly associated in 
patients with benign prostate enlargement. Hyperg lycemia became a significant 
risk factor  for  prostate  enlargement  in  patients  with  benign  prostate  
enlargement  in dr. Kariadi Hospital Semarang. 
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INTRODUCTION 
There were some changes in geriatric body tissue 
which was caused by the degeneration process, 
mainly body organs, where was no more cell 
developmental there. Degeneration causes dimin ished 
function  in  such  organ,  including  the  urinary  tract  
 
system, leading to various urological disorder or 
specific urological d isease.
2
 
Bladder   and   urethral   function   in elderly 
affected  by physiological  aging process in their 
systems,   for   example   in   bladder  anatomy  which  
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aging  characterized by the reducing muscle cells 
number and it rep laced by fatty and connective 
tissue.
7
 
Prostate is a male organ which might enlarge 
mostly, either benign or malignant. On benign 
prostate enlargement or benign prostatic hyperplasia 
(BPH)  the  periurethra g land enlarged, while the 
original prostate tissue   compelled   to   peripheral   
into   the capsule.  BPH arise  along with  age and  the 
etiology of BPH is closely related to degenerating 
process.
1,10
 
Several   theories   existed   about   the causes of  
BPH. Currently,  the most  widely adopted is it 
correlation with male hormones, especially 
testosterone. In prostate gland testosterone will be 
converted to Dehidro- testosteron (DHT). Then, DHT 
chronically stimulate   the   prostate   gland   to   
enlarge. Prostate enlargement was already apparent at 
25 years-old at about 25%. At the age of 80, nodules 
seen in 90% of which 50% of them were 
symptomatic.
6,8,9
 BPH patients usually sustained   
frequent   micturition,   mainly   at night, occasionally 
it can not be detained. When the pressing on urethra 
increases, urine discharge will be more difficult and 
urinary stream weakened till total retention.
3,4,5
 
Another factor that affects BPH were the 
background characteristics of the patient including 
age, family history, obesity, increased   cholesterol   
levels,   h igh   diet   in an imal  fat,  exercise,  
smoking, alcohol drinking, hyperglycemia and sexual 
activity.
5
 
Several investigators have reported the effect of 
age which increase BPH incidence, including study by 
Kojma et al regard ing the influence of age and 
prostate volume on symptom scores, which stated that 
there was a significant  relationship  between  BPH  
with age (p <0.0001).
4
 Obesity was thought to 
increase the risk of BPH, according to study of Lee,   
Body Mass Index BMI) was not associated with 
symptoms, instead of abdominal  circumference  and  
waist  to  hip ratio  (WHR)  which  implied  
abdominal obesity might increases the risk.
3
 
Studies assessed the relationship between benign 
prostate hyperplasia with isolated   hyperglycemia   
was   lacking.   This study will enrich informat ion on 
risk factors of  BPH,   primarily  its   relation  to   
hyperglycemia. 
 
MATERIALS AND METHODS  
This study utilized data from medical record   of   
BPH   patients   who   had   been admitted to 
dr.Kariadi Hospital. Inclusion criteria  were  
hospitalized   patients  in  dr. Kariadi  Hospital  whom 
clin ically diagnosed of prostate enlargement and 
underwent trans rectal ultra sound ultrasound 
examination. Patients with prostate malignancy were 
excluded from this study. 
Then, patients categorized into three age groups of 
30-40 years, 40-50 years, and 50-60 years. Normality 
test was performed if the data was abnormal. Then 
non-parametric Spearman test was  obtained to see the 
associaten between the variable.  
All part icipants were d ivided into two groups; case 
group were clinically-diagnosed BPH patients and 
laboratory-confirmed of hyperglycemia and recorded 
in the medical record, while control group were 
clin ically- diagnosed BPH patients and laboratory- 
confirmed of non-hyperglycemia and recorded in the 
medical record. Patients have already been diagnosed 
with controlled diabetes mellitus by an internist.  
Sample size calcu lation in various OR value was 
based on the largest sample calculat ion results, as the 
minimum sample in this study of 52 samples. The 
current study recruited 640 samples.  
Once the data collected, it was processed and the 
results presented in tables and boxplot. Data normality 
and homogeneity were tested by Kolmogorov 
normality test. Correlat ion between hyperglycemia 
and prostate volume conducted by Spearman 
correlation test. 
Differences were considered significant if P≤0.05 
with 95% confidence interval. Data analysis was 
performed with SPSS software Ver. 15.0. for 
Windows. 
 
RES ULTS  
We performed a retrospective analysis of clin ical  
data  from  640  part icipants  between 2010 and 2012 
who admitted to hospital with diagnosis of benign 
prostate enlargement. These  patients were evaluated 
through medical records that include plasma glucose 
level and prostate volume by transrectal ultrasound. 
Group 1 (P1) consist of 153 patients. After 
normality test performed the data was abnormal. By  
non-parametric Spearman test it obtained p = 0.000 
and r = 0.669 which implied strong positive 
association.  
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Group 2 (P2) consist of 176 patients. After 
normality test performed the data was abnormal. By  
non-parametric  Spearman test, it obtained p = 0.000 
and r = 0.672 which implied strong positive 
association. 
Group 3 (P3) consist of 311 patients. After 
normality test performed the data was abnormal. By  
non-parametric Spearman test it obtained p = 0.000 
and   r  = 0.415  which   implied   moderate    positive 
association. From the results of normality test with 
Shapiro-Wilk test on hyperglycemia and prostate 
volume variable, it was found the normal data 
distribution for each group. 
 
DISCUSS ION 
This study demonstrated the increased of prostate 
volume in male patients with benign prostate 
enlargement suffering from hyper- g lycemia. Men 
with a h istory of hyper- glycemia have greater risk of 
developing BPH compared with them with no history 
of hyperglycemia. 
Men with plasma glucose levels >110 mg/dL had 
three-fold greater risk of BPH, whereas men with 
Diabetes Mellitus have twice  risk  of  BPH  compared  
with  healthy men. Prev ious results found Odds Ratio 
(OR) in patients with hyperglycemia was 2.25 (95% 
CI: 1.23-4.11). 
Hyperglycemia which was part of the Metabolic 
Syndrome (MS) has been known as a risk factor for 
coronary heart disease. Major pathophysiology of 
hyperglycemia was secondary hyperinsulinemia 
caused by the presence   of   insulin   resistance   in   
tissues, which stimulates the autonomic nervous 
system, particularly sympathetic nervous system, 
resulting in bladder outlet obstruction. Generally, 
metabolic component in adults would increase with 
time. 
Several studies shown  that components of the 
metabolic syndrome like hyperglycemia was a risk 
factor for prostate hyperplasia. In 1998, Hammarsten 
et al reported an association between MS and prostatic 
hyperplasia. In their study, prostate enlargement were 
significantly higher in BPH patients with MS annually 
rather than in BPH patients without MS.  
 
 
 
 
 
 
 
 
 
Ozden et al examined 78 patients with prostatic 
hyperplasia and lower urinary tract symptoms and 
concluded that the presence of metabolic syndrome 
was strongly associated with greater prostate volume 
and median annual transition zone growth rate. Dahle 
et al demonstrated that some components of the 
metabolic syndrome (such as obesity and 
hyperinsulinemia)  were  associated  with higher risk 
of prostate hyperplasia. Some studies in Korea also 
reported that patients with metabolic syndrome tend to 
have larger prostate volume. 
Parsons et al reported positive relationship 
between prostate volume with obesity, elevated 
plasma glucose levels   and diabetes. This finding of 
men suffered from hyperglycemia and obesity has 
larger prostate size compared with men without this 
disorder demonstrated that hyperinsulinemia might be 
associated with the development of BPH, because all 
Figure 1.A.  Scattered plot of study population age 
30-40 years old 
 
Figure 1.C.  Scattered plot of study population age 
50-60 years old 
Figure 1.B.  Scattered plot of study population age 
40-50 years old 
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of these disorders were associated with 
hyperinsulinemia. Insulin resistance and secondary 
hyperinsulinemia play role in the relationship between 
MS and prostate enlargement. As shown in many 
studies, hyperglycemia and hyperinsulinemia were 
closely related. Hammrsten et al demonstrated that 
prostate hyperplasia might be associated with insulin 
resistance with secondary hyperinsulinemia   as   a   
possible   ethiologic factor in prostate enlargement. 
High insulin levels might induced prostate growth 
through various mechanisms. Either pathway that 
explain the increased risk o f prostate enlargement in  
hyperinsulinemia is insulin-like  growth   factor  (IGF)  
pathway. IGF-1 is a potent mitogen and increase cell 
proliferation and induces apoptosis in many tissue, 
including the prostate stroma and epithelium. In line 
with that, hyperglycemia tends to concomitant with 
hyperinsulinemia, which increase the insulin-like 
growth factor, which   known   as   prostate   mitogen,   
and inhibits apoptosis in prostate cascade. These 
convertion should play a role in the development of 
prostate tissue. Moreover, condition of 
hyperinsulinemia increase catecholamine levels in 
plasma and tissue that lead to a trophic effect on the 
development of prostate cells by lowering the 
progression of apoptosis. Thus explanation providing 
a concept of the relationship between hyper- 
insulinemia with an enlarged prostate tissue. 
In kariadi hospital, no study has ever been done to 
evaluate the correlation between hyperglycemia and 
prostate volume in patients with benign prostate 
enlargement.  
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